Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
34th week of 2019 patent applcation highlights part 9
Patent application number
Title
Published
20190255023
COMBINATION THERAPY COMPRISING A THIAZOLE AND A CORTICOSTEROID TO TREAT SKIN CONDITIONS
2019-08-22
20190255024
PHARMACEUTICAL FORMULATION COMPRISING CINEOLE AND AMOXICILLIN
2019-08-22
20190255025
METHODS AND COMPOSITIONS FOR ENHANCING FERTILITY AND/OR INHIBITING PREGNANCY FAILURE AND RESTORING GLUCOSE TOLERANCE
2019-08-22
20190255026
THERAPEUTIC AGENT FOR MEIBOMIAN DYSFUNCTION
2019-08-22
20190255027
METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
2019-08-22
20190255028
ADMINISTRATION OF BERBERINE METABOLITES
2019-08-22
20190255029
PHARMACEUTICAL COMPOSITIONS
2019-08-22
20190255030
Naproxen-Based Non-Steroidal Anti-Inflammatory Drug with Low Gastric Toxicity
2019-08-22
20190255031
CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALD- EHYDE
2019-08-22
20190255032
2,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System Disorders
2019-08-22
20190255033
Stable Nimodipine Parenteral Formulation
2019-08-22
20190255034
USE OF CDK9 INHIBITORS TO REDUCE CARTILAGE DEGRADATION
2019-08-22
20190255035
Nicotine Pouch
2019-08-22
20190255036
COMPOUND AND METHOD FOR REDUCING NEUROPATHIC PAIN AND DEPRESSION
2019-08-22
20190255037
Methods and Compositions for Treating Vasomotor Symptoms
2019-08-22
20190255038
PROCESS OF MAKING STABLE ABUSE-DETERRENT ORAL FORMULATIONS
2019-08-22
20190255039
Stable Oral Liquid Formulation of Trimetazidine
2019-08-22
20190255040
COMPOSITION AND METHOD FOR TOPICAL JS-K AS THERAPY FOR ACTINIC KERATOSIS
2019-08-22
20190255041
COMPOSITIONS AND METHODS FOR TREATING EZH2-MEDIATED CANCER
2019-08-22
20190255042
APPLICATION OF HEDGEHOG PATHWAY INHIBITOR IN TREATING FIBROSIS DISEASES
2019-08-22
20190255043
METHODS OF TREATMENT
2019-08-22
20190255044
TREATMENT AND PROGNOSTIC MONITORING OF PROLIFERATION DISORDERS USING HEDGEHOG PATHWAY INHIBITORS
2019-08-22
20190255045
TREATMENT AND PROGNOSTIC MONITORING OF PROLIFERATION DISORDERS USING HEDGEHOG PATHWAY INHIBITORS
2019-08-22
20190255046
TETRAHYDROQUINOLINE SUBSTITUTED HYDROXAMIC ACIDS AS SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS
2019-08-22
20190255047
2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES
2019-08-22
20190255048
PYRIMIDINE COMPOUND OR SALT THEREOF IN APPLICATION FOR MANUFACTURING PHARMACEUTICAL PRODUCT FOR PREVENTING AND/OR TREATING FLT3-RELATED DISEASE OR DISORDER
2019-08-22
20190255049
COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGRADATION
2019-08-22
20190255050
COMPOSITIONS AND METHODS FOR TREATING CANCER
2019-08-22
20190255051
TREATMENT OF BRAIN CANCER
2019-08-22
20190255052
Inhibitors of E1 Activating Enzymes
2019-08-22
20190255053
JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF CYTOKINE-RELATED DISORDERS
2019-08-22
20190255054
METHODS AND COMPOSITIONS FOR MANAGING NEUROINFLAMMATION AND NEURODEGENERATION
2019-08-22
20190255055
SMALL MOLECULE INHIBITORS OF ALDH AND USES THEREOF
2019-08-22
20190255056
A HCK INHIBITOR AND A BCL-2 INHIBITOR FOR TREATING ACUTE MYELOID LEUKEMIA
2019-08-22
20190255057
PYRAZOLOPYRIMIDINE COMPOUND AS PI3K INHIBITOR AND USE THEREOF
2019-08-22
20190255058
METHODS OF TREATING HEMATOLOGIC CANCERS
2019-08-22
20190255059
DUAL CLK/CDK1 INHIBITORS FOR CANCER TREATMENT
2019-08-22
20190255060
EZH2 INHIBITORS FOR TREATING LYMPHOMA
2019-08-22
20190255061
COMBINATION THERAPY WITH APILIMOD AND GLUTAMATERGIC AGENTS
2019-08-22
20190255062
DNA-PK INHIBITORS
2019-08-22
20190255063
COMBINATION OF PI3K-INHIBITORS
2019-08-22
20190255064
BENZIMIDAZOLE DERIVATIVES AS PI3 KINASE INHIBITORS
2019-08-22
20190255065
OPHTHALMIC COMPOSITIONS OF RIFAMYCINS AND USES THEREOF
2019-08-22
20190255066
FLUOROHYDROXYPROLINE DERIVATIVES USEFUL IN THE PREPARATION OF PROTEOLYSIS TARGETED CHIMERAS
2019-08-22
20190255067
HEPATITIS B CORE PROTEIN MODULATORS
2019-08-22
20190255068
PROSTACYCLIN ANALOGUE FORMULATIONS
2019-08-22
20190255069
METHODS OF TREATING CASTRATION-RESISTANT PROSTATE CANCER WITH GLUCOCORTICOID RECEPTOR ANTAGONISTS
2019-08-22
20190255070
PHARMACEUTICAL COMPOSITIONS
2019-08-22
20190255071
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
2019-08-22
20190255072
COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF
2019-08-22
20190255073
ESTERS OF 3-POLYAMINE DERIVATIVES OF BILE ACIDS FOR THE TREATMENT OF INFECTIONS
2019-08-22
20190255074
COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF VISUAL IMPAIRMENTS COMPRISING URSODEOXYCHOLIC ACID
2019-08-22
20190255075
TREATMENT OF PROSTATE CANCER
2019-08-22
20190255076
SMALL MOLECULE THERAPEUTIC COMPOUNDS THAT REDUCE THE INCIDENCE OF INTRACEREBRAL HEMORRHAGE AND BRAIN MICROHEMMORHAGES
2019-08-22
20190255077
Methods for Treating Heart Transplant Rejection
2019-08-22
20190255078
TOPICAL COMPOSITIONS WITH STABLE SOLUBILIZED SELECTIVE RETINOIDS AND/OR TETRACYCLINE-CLASS ANTIBIOTICS
2019-08-22
20190255079
COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES CHARACTERIZED BY INSUFFICIENT PANTOTHENATE KINASE ACTIVITY
2019-08-22
20190255080
METHOD OF REDUCING THYROID-ASSOCIATED SIDE EFFECTS
2019-08-22
20190255081
COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY
2019-08-22
20190255082
ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS
2019-08-22
20190255083
USE OF PURIFIED 2'-FUCOSYLLACTOSE, 3-FUCOSYLLACTOSE AND LACTODIFUCOTETRAOSE AS PREBIOTICS
2019-08-22
20190255084
DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF
2019-08-22
20190255085
METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS
2019-08-22
20190255086
Compositions and Methods for Treating an Infection
2019-08-22
20190255087
ENCAPSULATION AND HIGH LOADING EFFICIENCY OF PHOSPHORYLATED DRUG AND IMAGING AGENTS IN NANOPARTICLES
2019-08-22
20190255088
BIOCOMPATIBLE ORGANO-INORGANIC NANOCOMPOSITES
2019-08-22
20190255089
OLIGONUCLEOTIDES FOR TREATMENT OF SARCOMA
2019-08-22
20190255090
EGFR GENE EXPRESSION-SUPPRESSING SIRNA, PRECURSOR OF SAME, AND APPLICATIONS THEREOF
2019-08-22
20190255091
RNAi AGENTS FOR HEPATITIS B VIRUS INFECTION
2019-08-22
20190255092
ALGINATE OLIGOSACCHARIDES AND THE DERIVATIVES THEREOF AS WELL AS THE MANUFACTURE AND THE USE OF THE SAME
2019-08-22
20190255093
USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES
2019-08-22
20190255094
GUIDE RNA COMPLEMENTARY TO KRAS GENE, AND USE THEREOF
2019-08-22
20190255095
Compositions and Methods of Aloe Polysaccharides
2019-08-22
20190255096
LIPID-BASED OPHTHALMIC EMULSION
2019-08-22
20190255097
TREATMENT OF ALPHAVIRUS-INDUCED INFLAMMATION
2019-08-22
20190255098
INTRADIALYTIC USE OF SODIUM NITRITE
2019-08-22
20190255099
POLY-OXYGENATED METAL HYDROXIDE AND CBD
2019-08-22
20190255100
TREATMENT OF CARDIOVASCULAR DISEASE BY USING GALLIUM COMPOUNDS TO BIND CALCIFIED LESIONS
2019-08-22
20190255101
DIFFERENTIAL TUMOR CELL CYTOTOXICITY VIA CONTACT WITH COATED CERIUM OXIDE NANOPARTICLES
2019-08-22
20190255102
COMPOSITIONS AND METHODS OF TREATING DIABETIC RETINOPATHY
2019-08-22
20190255103
COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VENOM RELATED POISONING
2019-08-22
20190255104
ZINC-[GAMMA]-PGA COMPOSITIONS AND METHODS FOR TREATING CANCER
2019-08-22
20190255105
ANTIVIRAL COMPOSITION AND APPLICATIONS OF IRON-DOPED APATITE NANOPARTICLES
2019-08-22
20190255106
METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
2019-08-22
20190255107
MODULATION OF NOVEL IMMUNE CHECKPOINT TARGETS
2019-08-22
20190255108
CHIMERIC ANTIGEN RECEPTOR (CAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHODS OF USE THEREOF
2019-08-22
20190255109
METHODS OF USE FOR CAR T CELLS
2019-08-22
20190255110
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
2019-08-22
20190255111
CD38-NAD+ REGULATED METABOLIC AXIS IN ANTI-TUMOR IMMUNOTHERAPY
2019-08-22
20190255112
PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
2019-08-22
20190255113
PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
2019-08-22
20190255114
STORAGE OF PLATELETS
2019-08-22
20190255115
USE OF MESENCHYMAL STEM CELLS AND PARTS THEREOF
2019-08-22
20190255116
KIT FOR PREPARING DISEASE-TREATING AGENT, DISEASE-TREATING AGENT AND METHOD FOR PREPARING DISEASE-TREATING AGENT
2019-08-22
20190255117
SYNOVIOLIN EXPRESSION INHIBITOR CONTAINING MESENCHYMAL STEM CELL OR CULTURE SUPERNATANT THEREOF
2019-08-22
20190255118
CELL GROWTH METHOD AND PHARMACEUTICAL PREPARATION FOR TISSUE REPAIR AND REGENERATION
2019-08-22
20190255119
CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES TO RETARD OR REVERSE AGING AND AGE-RELATED DISORDERS
2019-08-22
20190255120
METHODS OF PREPARING AND USING NOVEL STEM CELL COMPOSITIONS AND KITS COMPRISING THE SAME
2019-08-22
20190255121
AGENT FOR PROMOTING EXPRESSION OF N-ACETYLGALACTOSAMINYLTRANSFERASE CONTAINING EXTRACT FROM INFLAMED TISSUES INOCULATED WITH VACCINIA VIRUS
2019-08-22
20190255122
PREBIOTIC BACTERIOPHAGE CONTAINING COMPOSITION FOR TREATMENT OF GASTROINTESTINAL INFLAMMATION
2019-08-22